Abstract:Background: Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable for universal healthcare access. Moreover, early market access of new oncology medicines lacking appropriate clinical evaluation generates uncertainty over their cost-effectiveness and increases expenditure for unknown health gain. Patient-level data can complement clinical trials and generate better evidence on the effectiveness, safety and outcomes of these new medicines in routine care. This can support policy decisions including funding. Consequently, there is a need for improving datasets for establishing real-world outcomes of newly launched oncology medicines. Aim: To outline the types of available datasets for collecting patient-level data for oncology among different European countries. Additionally, to highlight concerns regarding the use and availability of such data from a health authority perspective as well as possibilities for cross-national collaboration to improve data collection and inform decision-making. Methods: A mixed methods approach was undertaken through a cross-sectional questionnaire followed-up by a focus group discussion. Participants were selected by purposive sampling to represent stakeholders across different European countries and healthcare settings. Descriptive statistics were used to analyze quantifiable questions, whilst content analysis was employed for open-ended questions. Results: 25 respondents across 18 European countries provided their insights on the types of datasets collecting oncology data, including hospital records, cancer, prescription and medicine registers. The most available is expenditure data whilst data concerning effectiveness, safety and outcomes is less available, and there are concerns with data validity. A major constraint to data collection is the lack of comprehensive registries and limited data on effectiveness, safety and outcomes of new medicines. Data ownership limits data accessibility as well as possibilities for linkage, and data collection is time-consuming, necessitating dedicated staff and better systems to facilitate the process. Cross-national collaboration is challenging but the engagement of multiple stakeholders is a key step to reach common goals through research. Conclusion: This study acts as a starting point for future research on patient-level databases for oncology across Europe. Future recommendations will require continued engagement in research, building on current initiatives and involving multiple stakeholders to establish guidelines and commitments for transparency and data sharing.

Conducting national burden of disease studies and knowledge translation in eight small European states: challenges and opportunities

Burden of disease studies supporting policymaking in the European Union: a systematic review

Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices

Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany

What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate

The Burden of Disease due to COVID-19 (BoCO-19): A study protocol for a secondary analysis of surveillance data in Southern and Eastern Europe, and Central Asia

Methodological considerations in injury burden of disease studies across Europe: a systematic literature review

Burden of foodborne diseases: think global, act local

Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries

Strengthening disease surveillance capacity at national level across five countries: a qualitative study

Mapping the Global Research Landscape and Knowledge Gaps on Multimorbidity: A Bibliometric Study

Barriers and facilitators to dissemination of non-communicable diseases research: a mixed studies systematic review

National strategies for knowledge translation in health policy-making: A scoping review of grey literature

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries

Addressing chronic diseases: a comparative study of policies towards type-2 diabetes and hypertension in selected European countries

A systematic review of the methodological considerations in burden of disease studies

What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries

Barriers and facilitators to knowledge translation activities within academic institutions in low- and middle-income countries

Meeting statement: Call to action for step-change in health behaviours

Measuring and exploring the barriers to translating palliative care knowledge into clinical practice in rural and regional health-care settings

Practicalities of implementing burden of disease research in Africa: lessons from a population survey component of our multi-partner FOCAL research project